SCHEMBL8286134

SCHEMBL8286134

Cc1nc2c(cc1CNCc1ccccc1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
LMNA P02545 5/20 0.39
KDM4E B2RXH2 5/20 0.39
HTT P42858 4/20 0.39
PDE11A Q9HCR9 1/20 0.38
GPR55 Q9Y2T6 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
GAA P10253 2/20 0.38
NPC1 O15118 1/20 0.36
MAT2A P31153 1/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 4/20 0.35
MAPK1 P28482 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286131 0.89 MAPT (0.42) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8286420 0.88 PDE11A (0.40) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8285235 0.88 PDE11A (0.41) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8285219 0.87 PDE11A (0.39) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8287503 0.86 PDE11A (0.40) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8287150 0.86 PDE11A (0.40) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8287426 0.85 CYP3A4 (0.42) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8287892 0.84 PDE11A (0.39) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8285233 0.84 PDE11A (0.39) ALDH1A1LMNAKDM4EHTTPDE11A
SCHEMBL8286404 0.83 PDE11A (0.40) ALDH1A1LMNAKDM4EHTTPDE11A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed